Back to search

University of Washington

Evaluation of Potential Surrogate Endpoints

Abstract

dc:description.abstract

Valid surrogate endpoints can make clinical trials more efficient, allowing for more trials to be conducted and more rapid development of effective treatments. Identifying useful surrogates is a statistically challenging but extremely valuable endeavor. This work develops statistical methods for the evaluation and comparison of biomarkers as correlates of protection (CoP). Methods herein were developed with a focus on a time-to-event clinical endpoint and possible time-varying effects of treatment, an important and thus far neglected topic is CoP evaluation. We propose a novel Weibull model and three methods of estimation for use in CoP evaluation; simulations and real data examples demonstrate the characteristics of these methods.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Gabriel, Erin Evelyn
Advisor dc:contributor.advisor
  • Gilbert, Peter B

Subjects

dc:subject × 1

Rights

dc:rights
Statement dc:rights
  • Copyright is held by the individual authors.
Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/1773/21887

Chain of custody

source
Harvested from
University of Washington
Base URL
digital.lib.washington.edu/server/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Gabriel, Erin Evelyn. Evaluation of Potential Surrogate Endpoints. 2013. http://hdl.handle.net/1773/21887